Physician

Alexis Da Silva, MD

According to 2025 Medicare claims, Alexis Silva, MD (NPI: 1568857530) practices endocrinology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is PALM BEACH DIABETES AND ENDOCRINE SPECIALISTS PA (NPI: 1215941182; TIN: 650139716) and primary practice location at 33437-3587.

Silva's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 613 traditional Medicare patients, billed 11,669 HCPCS/CPT codes, and received $314,860 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,318 prescription claims across 868 beneficiaries totaling $3,307,329 in drug costs, led by Ozempic (Semaglutide). DME data shows 719 claims. Open Payments data shows 128 records totaling $2,733. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $32,768 to $314,860. Similarly, Part D prescription costs have risen steadily, from $980 to $3,307,329. For DME billing, reported payments moved sharply higher in recent years, from $438 to $180,557.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	135	1,548	$32,768
2021	227	6,082	$112,271
2022	384	9,747	$177,261
2023	563	8,764	$244,720
2024	613	11,669	$314,860

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	12	$980
2016	26	81	$9,254
2017	28	139	$12,547
2018	17	121	$8,421
2019	N/R	N/R	N/R
2020	114	315	$142,131
2021	336	2,021	$815,289
2022	566	3,651	$1,611,180
2023	765	5,516	$2,872,245
2024	868	7,318	$3,307,329

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	78	167	$19,392
2022	93	343	$51,344
2023	187	571	$74,453
2024	225	719	$186,693

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	512	1,139	$99
84443	Blood test, thyroid stimulating hormone (tsh)	443	882	$16
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	521	1,059	$13
84439	Thyroxine (thyroid chemical), free	441	870	$9
36415	Insertion of needle into vein for collection of blood sample	465	961	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	483	26,855	$805,201
Jardiance	Empagliflozin	372	27,930	$541,610
Mounjaro	Tirzepatide	252	10,538	$374,457
Trulicity	Dulaglutide	145	7,428	$243,553
Farxiga	Dapagliflozin Propanediol	107	8,156	$151,611

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	68	332	$143,792
E0784	External ambulatory infusion pump, insulin	Y	N/R	39	$13,745
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	26	$13,609
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	13	39	$9,631
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	82	167	$2,951

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	128	$2,733	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexis Da Silva, MD?

Tedicare shows public-source Medicare data for Alexis Da Silva, MD (NPI 1568857530), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexis Da Silva, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexis Da Silva, MD?

Alexis Da Silva, MD is linked to PALM BEACH DIABETES AND ENDOCRINE SPECIALISTS PA (billing NPI 1215941182) in the available physician profile data.

Does Alexis Da Silva, MD have Open Payments data?

Alexis Da Silva, MD has 128 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.